65 related articles for article (PubMed ID: 17257317)
1. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG
Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317
[TBL] [Abstract][Full Text] [Related]
2. Targeting BTLA with the peptide inhibitor HVEM(14-39) - A new way to restore the activity of T cells in melanoma.
Wojciechowicz K; Kuncewicz K; Rutkowski J; Jassem J; Rodziewicz-Motowidło S; Wardowska A; Spodzieja M
Biomed Pharmacother; 2024 Jun; 175():116675. PubMed ID: 38733770
[TBL] [Abstract][Full Text] [Related]
3. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R
Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628
[TBL] [Abstract][Full Text] [Related]
4. Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA.
Cheung TC; Atwell S; Bafetti L; Cuenca PD; Froning K; Hendle J; Hickey M; Ho C; Huang J; Lieu R; Lim S; Lippner D; Obungu V; Ward-Kavanagh L; Weichert K; Ware CF; Vendel AC
Structure; 2023 Aug; 31(8):958-967.e3. PubMed ID: 37279757
[TBL] [Abstract][Full Text] [Related]
5. B- and T-Lymphocyte Attenuator in Systemic Lupus Erythematosus Disease Pathogenesis.
Vendel AC; Jaroszewski L; Linnik MD; Godzik A
Clin Pharmacol Ther; 2024 Apr; ():. PubMed ID: 38676311
[TBL] [Abstract][Full Text] [Related]
6. Blockade of BTLA alone or in combination with PD-1 restores the activation and proliferation of CD8
Liu Y; Zhao Z; Su S; Li Y; Chen N; He L; Dong M; Xu B; Zhang Z; Zhou Y; Zhu Z
Vet Microbiol; 2024 Mar; 290():110004. PubMed ID: 38281324
[TBL] [Abstract][Full Text] [Related]
7. Peptides targeting the BTLA-HVEM complex can modulate T cell immune response.
Wojciechowicz K; Kuncewicz K; Lisowska KA; Wardowska A; Spodzieja M
Eur J Pharm Sci; 2024 Feb; 193():106677. PubMed ID: 38128840
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of binding specificity of HVEM for CD160 and BTLA ligands upon G89F mutation.
Shrestha R; Garrett-Thomson S; Liu W; Almo SC; Fiser A
Curr Res Struct Biol; 2021; 3():337-345. PubMed ID: 34917954
[TBL] [Abstract][Full Text] [Related]
9.
Lê H; Deforges J; Hua G; Idoux-Gillet Y; Ponté C; Lindner V; Olland A; Falcoz PE; Zaupa C; Jain S; Quéméneur E; Benkirane-Jessel N; Balloul JM
iScience; 2023 Oct; 26(10):108094. PubMed ID: 37860774
[TBL] [Abstract][Full Text] [Related]
10. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Gertner-Dardenne J; Fauriat C; Orlanducci F; Thibult ML; Pastor S; Fitzgibbon J; Bouabdallah R; Xerri L; Olive D
Blood; 2013 Aug; 122(6):922-31. PubMed ID: 23692853
[TBL] [Abstract][Full Text] [Related]
11. BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4
Yu X; Yang F; Shen Z; Zhang Y; Sun J; Qiu C; Zheng Y; Zhao W; Yuan S; Zeng D; Zhang S; Long J; Zhu M; Zhang X; Wu J; Ma Z; Zhu H; Su M; Xu J; Li B; Mao R; Su Z; Zhang J
Nat Commun; 2024 Feb; 15(1):1835. PubMed ID: 38418488
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CT-based radiomics model to predict natural killer cell infiltration and clinical prognosis in non-small cell lung cancer.
Meng X; Xu H; Liang Y; Liang M; Song W; Zhou B; Shi J; Du M; Gao Y
Front Immunol; 2023; 14():1334886. PubMed ID: 38283362
[TBL] [Abstract][Full Text] [Related]
13. BTLA biology in cancer: from bench discoveries to clinical potentials.
Andrzejczak A; Karabon L
Biomark Res; 2024 Jan; 12(1):8. PubMed ID: 38233898
[TBL] [Abstract][Full Text] [Related]
14. Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma - results of a prospective cohort study.
Tupikowski K; Partyka A; Pawlak EA; Ptaszkowski K; Zdrojowy R; Frydecka I; Hałoń A; Karabon L
Arch Med Sci; 2023; 19(5):1454-1462. PubMed ID: 37732048
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy.
Yu L; Sun M; Zhang Q; Zhou Q; Wang Y
Front Immunol; 2022; 13():982026. PubMed ID: 36159789
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Receptors Signaling in T Cells.
Baldanzi G
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408889
[TBL] [Abstract][Full Text] [Related]
17. Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis.
Lange A; Cajander S; Magnuson A; Strålin K; Hultgren O
PLoS One; 2022; 17(3):e0265818. PubMed ID: 35312715
[TBL] [Abstract][Full Text] [Related]
18. The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases.
Deng Z; Zheng Y; Cai P; Zheng Z
Front Immunol; 2021; 12():635623. PubMed ID: 34163466
[TBL] [Abstract][Full Text] [Related]
19. Roles of BTLA in Immunity and Immune Disorders.
Ning Z; Liu K; Xiong H
Front Immunol; 2021; 12():654960. PubMed ID: 33859648
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
